Jhunjhunwala backed Concord Biotech sets IPO price band at Rs 705-741

Jhunjhunwala firm-backed Concord Biotech sets IPO price band at Rs 705-741

ECB could hike rates or pause at next meeting: Christine Lagarde

Why ESG is a crucial investment despite the sceptics

Midcap darlings of conservative hybrid funds for long term growth

India pins hopes on bilateral local currency trade to internationalise rupee

Where to invest Rs 10 lakh today? Avoid small caps; just stick to these 2 fund categories, says D Muthukrishnan

MC Interview | Chartist Rohit Srivastava explains why the Nifty might not be done with the rally yet

Top 10 bets for August series as Nifty takes a breather but holds pivotal support

Daily Voice | Expect tech stocks to stabilize or slightly rise in Q2FY24 post Q1 earnings, says Rohit Agarwal of Kotak Mahindra Life